Transformational Pediatrics

The GERD, The Bad, The Ugly: When Dosing Guidelines Ignore A BIG Problem

Valentina Shakhnovich, MD - Speaker Bio
Valentina Shakhnovich, MD, is an Assistant Professor of Pediatrics and Associate Program Director for Gastroenterology Fellowship Research Program at Children’s Mercy Kansas City. Dr Shakhnovich is one of two double fellowship trained pediatric gastroenterologist and clinical pharmacologist in the nation. She completed her residency in pediatrics at the University of Wisconsin School of Medicine in 2011 followed by a fellowship in Clinical Pharmacology and Pediatric Gastroenterology at Children’s Mercy Kansas City in 2015.

Learn more about Valentina Shakhnovich, MD
  • Topic Info:The medications used to treat gastroesophageal reflux (GERD) in children ignore one BIG factor – obesity. Obesity is a known risk factor for GERD in children, but the proton pump inhibitor (PPI) pantoprazole commonly used to treat GERD has no dosing guidelines for overweight and obese children.

    Dr. Shakhnovich is here to explain that through her research, she has found that giving overweight children larger doses, a recently suggested practice with adults, could actually cause more harm than good and predispose children to unwanted side-effects from unintentional systemic overexposure to PPIs.